Dr. Andrew Pearce MD, Health Sciences North Research Institute, NorthEast Cancer Centre
Dr. Ryan Carlson MD, Health Sciences North Research Institute, NorthEast Cancer Centre
Dr. Mike Conlon holds a PhD in epidemiology and biostatistics. He is a cancer epidemiologist and director of Epidemiology, Outcomes, and Evaluation Research at the Health Sciences North Research Institute. He holds academic appointments at Health Sciences North Research Institute (HSNRI), is an Associate Professor at the Northern Ontario School of Medicine (NOSM), an Adjunct Scientitst at (ICES), and holds appointments at Laurentian and Lakehead Universities. He is the inaugral director the ICES North satellite site, which is located at Health Sciences North Research Insitute. His research interests are collaborative and often focus on causes and clinical outcomes from care, and health services associated research in NE cancer patients.
Dr. Andrew Pearce is the head of Service, Radiation Oncology and he and Dr. Ryan Carlson are clinical specialists (Radiation Oncologists) who treat men with prostate cancer at the North East Cancer Centre. They both hold appointments at the Northern Ontario School of Medicine (NOSM) and have extensive clinical experience and knowldege related to diagnoses, treatment options, timing, and outcomes from care. They have previously, and continue to participate in observational, clinical, and trial research with a goal to optimizing outcomes from treatment in Northeastern Ontario for men with prostate cancer.
We provide the following objectives:
1) To identify a cohort of men with newly diagnosed prostate cancer in Ontario, and report the incidence rates within important geographic regions including Northeastern Ontario;
2) To determine the stage at diagnoses for all cases, and assess differences within geographic regions, as well as the role that other important sociodemographic variables may have with with later stage at presentation (i.e. age, income quintile, rurality, comorbidities, and others);
3) To determine the treatment received (stratified by stage at diagnoses) and assess differences across geographic regions;
4) To determine survival by stage, and assess differences based on geographic region, rurality, and other potential covariates.
This project will help to identify opportunities to improve prostate cancer outcomes for men in Northeastern Ontario.